Analyze Diet

Topic:Pharmaceuticals

Pharmaceuticals in equine medicine encompass a wide range of drugs and therapeutic agents used to treat various conditions in horses. These substances include analgesics, anti-inflammatories, antibiotics, sedatives, and anthelmintics, among others. Each class of pharmaceuticals is designed to address specific health issues, such as pain management, infection control, or parasitic infestations. The pharmacokinetics and pharmacodynamics of these drugs can vary significantly between horses and other species, necessitating careful consideration of dosage and administration methods. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, safety, and regulatory aspects of pharmaceuticals used in equine healthcare.
Metabolic studies of formestane in horses.
Drug testing and analysis    January 21, 2013   Volume 5, Issue 6 412-419 doi: 10.1002/dta.1444
Leung GN, Kwok WH, Wan TS, Lam KK, Schiff PJ.Formestane (4-hydroxyandrost-4-ene-3,17-dione) is an irreversible steroidal aromatase inhibitor with reported abuse in human sports. In 2011, our laboratory identified the presence of formestane in a horse urine sample from an overseas jurisdiction. This was the first reported case of formestane in a racehorse. The metabolism of formestane in humans has been reported previously; however, little is known about its metabolic fate in horses. This paper describes the in vitro and in vivo metabolic studies of formestane in horses, with the objective of identifying the target metabolite with the lon...
A Bayesian approach for estimating detection times in horses: exploring the pharmacokinetics of a urinary acepromazine metabolite.
Journal of veterinary pharmacology and therapeutics    January 16, 2013   Volume 36, Issue 1 31-42 doi: 10.1111/j.1365-2885.2013.01389.x
McGree JM, Noble G, Schneiders F, Dunstan AJ, McKinney AR, Boston R, Sillence M.We describe the population pharmacokinetics of an acepromazine (ACP) metabolite (2-(1-hydroxyethyl)promazine) (HEPS) in horses for the estimation of likely detection times in plasma and urine. ACP (30 mg) was administered to 12 horses, and blood and urine samples were taken at frequent intervals for chemical analysis. A bayesian hierarchical model was fitted to describe concentration-time data and cumulative urine amounts for HEPS. The metabolite HEPS was modelled separately from the parent ACP as the half-life of the parent was considerably less than that of the metabolite. The clearance (Cl/...
Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.
Analytical and bioanalytical chemistry    January 15, 2013   Volume 405, Issue 8 2595-2606 doi: 10.1007/s00216-012-6697-9
Kwok WH, Ho EN, Lau MY, Leung GN, Wong AS, Wan TS.In recent years, there has been an ongoing focus for both human and equine doping control laboratories on developing detection methods to control the misuse of peptide therapeutics. Immunoaffinity purification is a common extraction method to isolate peptides from biological matrices and obtain sufficient detectability in subsequent instrumental analysis. However, monoclonal or polyclonal antibodies for immunoaffinity purification may not be commercially available, and even if available, such antibodies are usually very costly. In our study, a simple mixed-mode anion exchange solid-phase extra...
Validated UHPLC-MS-MS method for rapid analysis of capsaicin and dihydrocapsaicin in equine plasma for doping control.
Journal of analytical toxicology    January 11, 2013   Volume 37, Issue 2 122-132 doi: 10.1093/jat/bks098
You Y, Uboh CE, Soma LR, Guan F, Taylor D, Li X, Liu Y, Chen J.A method involving ultra high-performance liquid chromatography-tandem mass spectrometry was developed and validated for the analysis of capsaicin and dihydrocapsaicin in equine plasma. The analytes were recovered from plasma by liquid-liquid extraction using methyl tert-butyl ether and separated on a sub-2 micron column. The mobile phase was composed of 2 mM ammonium formate and methanol. A triple quadrupole mass spectrometer was used to detect the analytes in positive electrospray ionization mode with selected reaction monitoring. The limits of detection, quantification and confirmation for ...
Misoprostol: is it safety or a lack of understanding that prevents its more frequent usage?
Equine veterinary journal    December 13, 2012   Volume 45, Issue 1 8 doi: 10.1111/evj.12017
Blikslager AT.No abstract available
[Vigilance for veterinary medicinal products: reports of adverse reactions in the year 2011].
Schweizer Archiv fur Tierheilkunde    November 29, 2012   Volume 154, Issue 12 513-519 doi: 10.1024/0036-7281/a000400
Müntener CR, Bruckner L, Kupper J, Althaus F, Caduff-Janosa P.167 adverse reactions of Swissmedic-authorized veterinary medicinal products were reported during the year 2011 (2010: 160). Species and drug classes remain comparable with previous years: most of the reactions occurred following the use of antiparasitic products (39 %), antiinfectives (20 %) or non-steroidal antiinflammatory drugs (11 %) in companion animals (85 dogs and 27 cats) followed by cattle/calves (37). We received 15 cases of adverse reactions following reconverted use, 8 of them in treated cats. Additionally the Swiss Toxicological Information Centre in Zürich processed 84 enquirie...
Where does it hurt?
Equine veterinary journal    October 31, 2012   Volume 44, Issue 6 627-628 doi: 10.1111/j.2042-3306.2012.00661.x
Barr AR.No abstract available
Pharmacokinetics of macrolides in foals.
Journal of veterinary pharmacology and therapeutics    October 22, 2012   Volume 36, Issue 1 1-13 doi: 10.1111/jvp.12010
Villarino N, Martín-Jiménez T.Macrolides are used for treatment of pneumonia and extrapulmonary conditions caused by Rhodococcus equi. In foals, macrolides have an extraordinary capacity to accumulate in different lung tissue compartments. These drugs show unique pharmacokinetic features such as rapid and extensive distribution and long persistence in pulmonary epithelial lining fluid (PELF) and bronchoalveolar lavage (BAL) cells from foals. This article reviews the pharmacokinetic characteristics of erythromycin, azithromycin, clarithromycin, tulathromycin, telithromycin, gamithromycin, and tilmicosin in foals, with empha...
[New drugs for horses and production animals in 2011].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    October 19, 2012   Volume 40, Issue 5 301-308 
Emmerich IU.In 2011, three newly developed active pharmaceutical ingredients for horses and food producing animals were released on the German market for veterinary drug products. Two of these new products represent different drug classes of antibiotics, the polypeptide antibiotic Bacitracin (Bacivet™) and the macrolide antibiotic Clorsulon (Levatum®). The third product represents an anticestodal antiparasitic (Tildipirosin, Zuprevo®). Furthermore, three established veterinary active pharmaceutical ingredients were modified to allow their application for additional species. Thus the nonsteroidal anti-...
Pharmacokinetics and adverse effects of oral meloxicam tablets in healthy adult horses.
Journal of veterinary pharmacology and therapeutics    October 15, 2012   Volume 36, Issue 4 376-381 doi: 10.1111/jvp.12021
Vander Werf KA, Davis EG, Kukanich B.The objective of this study was to assess the pharmacokinetic profile and determine whether any adverse effects would occur in seven healthy adult horses following oral meloxicam tablet administration once daily for 14 days at a dose of 0.6 mg/kg·bwt. Horses were evaluated for health using physical examination, complete blood count, serum chemistry, urinalysis, and gastroscopy at the beginning and end of the study. Blood was collected for the quantification of meloxicam concentrations with liquid chromatography and mass spectrometry. The mean terminal half-life was 4.99 ± 1.11 h. There was n...
Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry.
Journal of chromatography. A    September 23, 2012   Volume 1265 57-69 doi: 10.1016/j.chroma.2012.09.043
Ho EN, Kwok WH, Lau MY, Wong AS, Wan TS, Lam KK, Schiff PJ, Stewart BD.A veterinary preparation known as TB-500 and containing a synthetic version of the naturally occurring peptide LKKTETQ has emerged. The peptide segment (17)LKKTETQ(23) is the active site within the protein thymosin β(4) responsible for actin binding, cell migration and wound healing. The key ingredient of TB-500 is the peptide LKKTETQ with artificial acetylation of the N-terminus. TB-500 is claimed to promote endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition and decrease inflammation. In order to control the misuse of TB-500 in equin...
Detection of peginesatide in equine serum using liquid chromatography-tandem mass spectrometry for doping control purposes.
European journal of mass spectrometry (Chichester, England)    September 14, 2012   Volume 18, Issue 4 407-412 doi: 10.1255/ejms.1189
Möller I, Thomas A, Wingender A, Machnik M, Schänzer W, Thevis M.Erythropoietin (EPO) and its recombinant analogues are suspected to be illicitly administered to horses for performance enhancing purposes and, consequently, prohibited in equine sports. Recently, a new erythropoiesis-stimulating agent, peginesatide (Omontys, formerly referred to as Hematide), belonging to the upcoming class of EPO-mimetic peptides, received approval for the treatment of anaemia in humans with chronic kidney disease on dialysis. As the pegylated dimeric peptide of approximately 45 kDa without sequence homology to EPO is not detectable by conventional EPO detection assays, spec...
Pharmacokinetics of methylprednisolone acetate after intra-articular administration and subsequent suppression of endogenous hydrocortisone secretion in exercising horses.
American journal of veterinary research    August 29, 2012   Volume 73, Issue 9 1453-1461 doi: 10.2460/ajvr.73.9.1453
Menéndez MI, Phelps MA, Hothem EA, Bertone AL.To determine the pharmacokinetics of methylprednisolone (MP) and the relationship between MP and hydrocortisone (HYD) concentrations in plasma and urine after intra-articular (IA) administration of 100 or 200 mg of MP acetate (MPA) to horses. Methods: Five 3-year-old Thoroughbred mares. Methods: Horses exercised on a treadmill 3 times/wk during the study. Horses received 100 mg of MPA IA, then 8 weeks later received 200 mg of MPA IA. Plasma and urine samples were obtained at various times for 8 weeks after horses received each dose of MPA; concentrations of MP and HYD were determined. Pharmaco...
Expression of pleiotrophin, an important regulator of cell migration, is inhibited in intestinal epithelial cells by treatment with non-steroidal anti-inflammatory drugs.
Growth factors (Chur, Switzerland)    June 13, 2012   Volume 30, Issue 4 258-266 doi: 10.3109/08977194.2012.693920
Silver K, Desormaux A, Freeman LC, Lillich JD.Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs for the suppression of inflammation and pain. However, the analgesic properties of NSAIDs are also associated with significant negative side effects, most notably in the gastrointestinal (GI) tract. Increasingly, evidence indicates that the ulcerogenic properties of some NSAIDs are not exclusively the result of inhibition of cyclooxygenase isoforms in the GI tract, and other mechanisms, including inhibition of cell migration and epithelial restitution, are being explored. Recently, microarray analysis was used ...
Structural and immunologic characterization of bovine, horse, and rabbit serum albumins.
Molecular immunology    June 6, 2012   Volume 52, Issue 3-4 174-182 doi: 10.1016/j.molimm.2012.05.011
Majorek KA, Porebski PJ, Dayal A, Zimmerman MD, Jablonska K, Stewart AJ, Chruszcz M, Minor W.Serum albumin (SA) is the most abundant plasma protein in mammals. SA is a multifunctional protein with extraordinary ligand binding capacity, making it a transporter molecule for a diverse range of metabolites, drugs, nutrients, metals and other molecules. Due to its ligand binding properties, albumins have wide clinical, pharmaceutical, and biochemical applications. Albumins are also allergenic, and exhibit a high degree of cross-reactivity due to significant sequence and structure similarity of SAs from different organisms. Here we present crystal structures of albumins from cattle (BSA), h...
Pharmacokinetics of a continuous rate infusion of ceftiofur sodium in normal foals.
Journal of veterinary pharmacology and therapeutics    May 21, 2012   Volume 36, Issue 1 99-101 doi: 10.1111/j.1365-2885.2012.01403.x
Wearn JM, Davis JL, Hodgson DR, Raffetto JA, Crisman MV.No abstract available
Treatment with histamine-type 2 receptor antagonists and omeprazole increase the risk of diarrhoea in neonatal foals treated in intensive care units.
Equine veterinary journal. Supplement    May 19, 2012   Issue 41 80-86 doi: 10.1111/j.2042-3306.2011.00499.x
Furr M, Cohen ND, Axon JE, Sanchez LC, Pantaleon L, Haggett E, Campbell R, Tennent-Brown B.The use of anti-ulcer medication in the neonatal intensive care unit (ICU) is common due to the concern for development of catastrophic gastric ulcerdisease. In man, however, the use of acid-suppressive medication has been shown in some studies to be a substantial riskfactorfor the development of Clostridium difficile-associated diarrhoea (CDAD), bacteraemia and neonatal sepsis. Objective: The purpose of the study reported herein is to evaluate the influence of anti-ulcer medications on the development of diarrhoea in the neonatalfoal. Objective: The use of anti-ulcer medication does not alter...
Comparative performance of macrocyclic lactones against large strongyles in horses.
Parasitology international    May 8, 2012   Volume 61, Issue 4 550-553 doi: 10.1016/j.parint.2012.05.001
Toscan G, Cezar AS, Pereira RC, Silva GB, Sangioni LA, Oliveira LS, Vogel FS.Several formulations of macrocyclic lactones (abamectin, ivermectin, moxidectin), including ivermectin combined with pyrantel (tetrahydropyrimidine) and ivermectin combined with praziquantel (pyrazinoisoquinolin derivative), were tested regarding their efficacy to control gastrointestinal nematodes of horses on a stud farm in southern Brazil. In addition, we tested a pharmaceutically produced generic paste containing ivermectin 4%. Similar formulations of avermectins had different efficacies measured by reduction of EPG. Levels of efficacy of the tested drugs varied against Strongylus edentatu...
Structural elucidation of phase I and II metabolites of bupivacaine in horse urine and fungi of the Cunninghamella species using liquid chromatography/multi-stage mass spectrometry.
Rapid communications in mass spectrometry : RCM    May 5, 2012   Volume 26, Issue 11 1338-1346 doi: 10.1002/rcm.6225
Rydevik A, Bondesson U, Hedeland M.Bupivacaine is a local anaesthetic prohibited in equine sports. It is highly metabolized in the horse but a thorough description of its metabolite profile is lacking. An administration study should find appropriate analytical targets for doping control. Furthermore, knowledge of an in vitro system for production of metabolites would be beneficial. Methods: Marcain® (bupivacaine hydrochloride) was administered subcutaneously to a horse and urine samples were collected. In vitro metabolic systems consisting of the fungi Cunninghamella elegans and Cunninghamella blakesleeana were incubated with ...
Detection of recombinant human EPO administered to horses using MAIIA lateral flow isoform test.
Analytical and bioanalytical chemistry    April 18, 2012   Volume 403, Issue 6 1619-1628 doi: 10.1007/s00216-012-5972-0
Lönnberg M, Bondesson U, Cormant F, Garcia P, Bonnaire Y, Carlsson J, Popot MA, Rollborn N, Råsbo K, Bailly-Chouriberry L.Doping of horses with recombinant human erythropoietin (rHuEPO) to illegally enhance their endurance capacity in horseracing has been reported during the last years. This leads to increased blood viscosity which can result in sudden death and is of concern for the horse welfare. Additionally, the horse can start production of rHuEPO antibodies, which cross-reacts with endogenous equine EPO and can lead to severe anaemia and even death. In this study, a novel micro-chromatographic method, EPO WGA MAIIA, has been tested for the capability in plasma and urine samples to detect administration of e...
Efficacy of omeprazole paste in the prevention of gastric ulcers in 2 years old Thoroughbreds.
The Journal of veterinary medical science    April 13, 2012   Volume 74, Issue 8 1079-1081 doi: 10.1292/jvms.11-0545
Endo Y, Tsuchiya T, Sato F, Murase H, Omura T, Korosue K, Nambo Y, Ishimaru M, Wakui Y.Prevalence of equine gastric ulcer syndrome in 85 young Thoroughbreds was investigated. The presence of gastric ulcers was confirmed in 27.1% (23/85) of the horses by endoscopic examination. Sixty-two horses without gastric ulcers were allocated randomly to either the treated group (31 horses) or sham-dosed control group (31 horses) in order to investigate the efficacy of omeprazole oral paste in the prevention of gastric ulcers. At the second endoscopic examination conducted after 28 days of administration, only 1 horse in the treated group developed gastric ulcers, while 12 horses developed ...
Pharmacokinetics of stanozolol in Thoroughbred horses following intramuscular administration.
Journal of veterinary pharmacology and therapeutics    April 11, 2012   Volume 36, Issue 2 201-204 doi: 10.1111/j.1365-2885.2012.01393.x
Moeller BC, Sams RA, Guingab-Cagmat JD, Szabo NJ, Colahan P, Stanley SD.No abstract available
[Should “welfare” medication be allowed back?].
Tijdschrift voor diergeneeskunde    March 1, 2012   Volume 137, Issue 1 10-13 
van Weezel-Errens A.No abstract available
Detection of myo-inositol trispyrophosphate in equine urine and plasma by hydrophillic interaction chromatography-tandem mass spectrometry.
Drug testing and analysis    February 22, 2012   Volume 4, Issue 5 355-361 doi: 10.1002/dta.397
Wong AS, Ho EN, Wan TS.Myo-inositol trispyrophosphate (ITPP) is a new drug capable of increasing the amount of oxygen in hypoxic tissues. Studies have shown that administration of ITPP increases the maximal exercise capacity in normal mice as well as mice with severe heart failure. The properties of ITPP make it an ideal candidate as a doping agent to enhance performance in racehorses. While there have been speculations in the horseracing industry that the covert use of ITPP is already widespread, no reported method exists for the detection of ITPP in equine biological samples. ITPP is a difficult-to-detect drug due...
Treatment of ivermectin overdose in a miniature Shetland Pony using intravenous administration of a lipid emulsion.
Journal of veterinary internal medicine    February 2, 2012   Volume 26, Issue 2 407-411 doi: 10.1111/j.1939-1676.2011.00865.x
Bruenisholz H, Kupper J, Muentener CR, Dally A, Kraemer T, Naegeli H, Schwarzwald CC.No abstract available
Pharmacokinetics of firocoxib and its interaction with enrofloxacin in horses.
Journal of veterinary pharmacology and therapeutics    January 11, 2012   Volume 35, Issue 6 615-617 doi: 10.1111/j.1365-2885.2011.01362.x
Cox S, Dudenbostel L, Sommardahl C, Yarbrough J, Saleh M, Doherty T.No abstract available
[New drugs for horses and production animals in 2010].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    December 15, 2011   Volume 39, Issue 6 384-390 
Emmerich IU.In 2010, three new active pharmaceutical ingredients were released on the German market for horses and food-producing animals. These were gamithromycin (Zactran®), a new macrolide antibiotic, Monepantel (Zolvix®), a broad spectrum anthelmintic with a novel mechanism, and Pergolide (Prascend®), the first dopamine receptor agonist for animals. Two substances have been approved for additional species. The tetracycline antibiotic doxycycline is now also authorized for turkeys and the nonsteroidal anti-inflammatory drug firocoxib from the group of cyclo-oxygenase-2 (COX-2) inhibitors is now avai...
[Use of local anaesthetics in the horse. Pharmacological and legal aspects].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    December 6, 2011   Volume 39, Issue 2 117-123 
Kästner S.No abstract available
Pharmacokinetics of concurrently administered intravenous lidocaine and flunixin in healthy horses.
Journal of veterinary pharmacology and therapeutics    December 2, 2011   Volume 35, Issue 4 413-416 doi: 10.1111/j.1365-2885.2011.01356.x
Waxman SJ, KuKanich B, Milligan M, Beard WL, Davis EG.No abstract available
Toxins and adverse drug reactions affecting the equine nervous system.
The Veterinary clinics of North America. Equine practice    November 22, 2011   Volume 27, Issue 3 507-526 doi: 10.1016/j.cveq.2011.08.003
Dawson DR.This article provides an overview of the more common toxins and adverse drug reactions, along with more rare toxins and reactions (Table 1), that result in neurologic dysfunction in horses. A wide variety of symptoms, treatments, and outcomes are seen with toxic neurologic disease in horses. An in-depth history and thorough physical examination are needed to determine if a toxin or adverse drug reaction is responsible for the clinical signs. Once a toxin or adverse drug reaction is identified, the specific antidote, if available, and supportive care should be administered promptly.
1 8 9 10 11 12 36